FDA — authorised 28 October 2021
- Application: NDA214028
- Marketing authorisation holder: ABBVIE
- Local brand name: VUITY
- Indication: SOLUTION/DROPS — OPHTHALMIC
- Status: approved
🇺🇸 Pilocarpine Ophthalmic Solution in United States
FDA authorised Pilocarpine Ophthalmic Solution on 28 October 2021
Marketing authorisation
Other Ophthalmology approved in United States
Frequently asked questions
Is Pilocarpine Ophthalmic Solution approved in United States?
Yes. FDA authorised it on 28 October 2021.
Who is the marketing authorisation holder for Pilocarpine Ophthalmic Solution in United States?
ABBVIE holds the US marketing authorisation.